AccessibilityHelpAbout Us
Novo Integrated Sciences logo

Novo Integrated Sciences(OTC) NVOS

Market Cap$76.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year-29%
1 Month+73%
$0.00
+0.00%
+0.00Today
Novo Integrated Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-16
Novo Integrated Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-04
1 month+73.33%USD 0.002026-08-17
3 month+457.14%USD 0.002026-06-18
Year to date+44.44%USD 0.002025-12-31
1 year-29.09%USD 0.012025-09-16
3 year-99.9%USD 4.002023-09-15
5 year-99.98%USD 18.902021-09-17
Since inception-100%USD 84.002017-05-10

Novo Integrated Sciences Financials at a Glance

Market Cap

$76.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$13.29M

Net Income (TTM)

-$16.17M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-8.20 (Low)

Price

$0.00

Volume

37

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

Jul 21, 2025

NVOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Integrated Sciences

Novo Integrated Sciences, Inc. is a healthcare company that provides a wide range of primary healthcare services and products. The company operates through two main segments: Healthcare Services and Product Manufacturing and Development, focusing on innovative therapeutic approaches and wellness solutions.

Products and Services
  • Comprehensive healthcare services including physiotherapy, chiropractic care, and occupational therapy
  • Specialized treatments such as acupuncture, functional dry needling, and advanced rehabilitation
  • Telemedicine consultations and remote patient monitoring for enhanced patient care
Growth Outlook
  • Recent quarterly revenue reached $3.08 million, indicating strong service demand
  • Gross profit margin improved to 51.2% in the latest quarter, showcasing operational efficiency
  • Expansion of service offerings aims to capture a larger market share in healthcare
Financial Highlights
  • Trailing twelve months revenue totaled $12.5 million, reflecting consistent growth
  • Net income for the latest quarter was $5.0 million, a significant turnaround
  • Cash and cash equivalents stood at $844,584, providing liquidity for operations
Novo Integrated Sciences, Inc. is dedicated to addressing a variety of healthcare needs across all age demographics. The company operates a network of 16 clinics and emphasizes innovative treatment methods, including trauma-sensitive yoga and meditation for recovery. The recent financial performance indicates a positive trajectory, with a notable increase in revenue and gross profit margins. The focus on expanding service offerings and leveraging technology positions the company for future growth in the evolving healthcare landscape.
AI Generated • Sep 10, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

264

CEO

Robert Mattacchione

Website

novointegrated.com

Headquarters

Bellevue, WA 98004, US

NVOS Financials

Key Financial Metrics (TTM)

Gross Margin

43.20%

Operating Margin

-62.54%

Net Income Margin

-121.32%

Return on Equity

-81.23%

Return on Capital

-42.41%

Return on Assets

-50.18%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$76.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

19.73M

Volume

37

Avg. Volume

5.23K

Financials (TTM)

Gross Profit

$5.74M

Operating Income

-$8.31M

EBITDA

-$6.64M

Operating Cash Flow

-$5.07M

Capital Expenditure

-$5.04K

Free Cash Flow

-$5.07M

Cash & ST Invst.

$844.58K

Total Debt

$4.71M

Novo Integrated Sciences Performance Analysis

Novo Integrated Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31USD 11,737,937N/A
20232023-08-31USD 12,572,0197.1%
20242024-08-31USD 13,294,3575.7%
Novo Integrated Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-11-3017.8%
Q22024-02-29-18.5%
Q32024-05-31-0.6%
Q42024-08-31-2.3%
Novo Integrated Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31USD -11.28N/A
20232023-08-31USD -1.30-88.5%
20242024-08-31USD -0.90-31.0%
Novo Integrated Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-11-30-40.0%
Q22024-02-2942.9%
Q32024-05-31-362.5%
Q42024-08-31135.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$3.08M

-6.7%

Gross Profit

$1.58M

+70.0%

Gross Margin

51.21%

N/A

Market Cap

$76.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$668.70

N/A

Employees

115

N/A

Net Income

$5.00M

+258.3%

EBITDA

$7.25M

+440.7%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$844.58K

+102.9%

Total Debt

$4.71M

+5.3%

Accounts Receivable

$3.15M

+114.9%

Inventory

$1.00M

-9.6%

Long Term Debt

$2.99M

+70.2%

Short Term Debt

$3.16M

+16.4%

Return on Assets

-50.18%

N/A

Return on Invested Capital

-47.34%

N/A

Free Cash Flow

-$548.95K

-111.8%

Operating Cash Flow

-$545.92K

-138.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SETOSETO Holdings, Inc.
$0.01+0.00%
JNHMFJack Nathan Medical Corp.
$0.00+0.00%
BBBTBlack Bird Biotech, Inc.
$0.00+0.00%
OMHEOMNI Health, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MEDSDataMEDS Ai
$6.07+274.69%
AALAmerican Airlines Group
$12.70-0.55%
NOKNokia
$10.14+3.05%
INTCIntel
$101.05+4.03%

Questions About NVOS

What is the current price of Novo Integrated Sciences?

Novo Integrated Sciences is trading at $0.00 per share.

What is the 52-week range for Novo Integrated Sciences?

Over the past 52 weeks, Novo Integrated Sciences has traded between $0.00 and $0.06.

How much debt does Novo Integrated Sciences have?

As of the most recent reporting period, Novo Integrated Sciences reported total debt of $5.98M.

How much cash does Novo Integrated Sciences have on hand?

Novo Integrated Sciences reported $844.58K in cash and cash equivalents in its most recent financial results.

What is Novo Integrated Sciences’s dividend yield?

Novo Integrated Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services